Patents by Inventor Andrea DEERBERG

Andrea DEERBERG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11828758
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof. The recombinant peptide may be a monomer, a dimer, or a hexamer.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: November 28, 2023
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • Patent number: 11519919
    Abstract: A diagnostically useful carrier includes (a) a peptide including the amino acid sequence set forth in SEQ ID NO:1 or a variant thereof, and (b) a somatic lysate of Toxocara canis larvae. Further, a kit, use, methods, and compositions that include the diagnostically useful carrier are disclosed.
    Type: Grant
    Filed: June 30, 2020
    Date of Patent: December 6, 2022
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Babett Menge, Katja Steinhagen, Juliane Schaefer, Christian Probst, Andrea Deerberg, Mandy Unger, Claudia Messing
  • Publication number: 20210033609
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO: 1 or a variant thereof. The recombinant peptide may be a monomer, a dimer, or a hexamer.
    Type: Application
    Filed: October 1, 2020
    Publication date: February 4, 2021
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • Publication number: 20210003591
    Abstract: A diagnostically useful carrier includes (a) a peptide including the amino acid sequence set forth in SEQ ID NO:1 or a variant thereof, and (b) a somatic lysate of Toxocara canis larvae. Further, a kit, use, methods, and compositions that include the diagnostically useful carrier are disclosed.
    Type: Application
    Filed: June 30, 2020
    Publication date: January 7, 2021
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Babett MENGE, Katja Steinhagen, Juliane Schaefer, Christian Probst, Andrea Deerberg, Mandy Unger, Claudia Messing
  • Patent number: 10837963
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO1 or a variant thereof, where the recombinant polypeptide is a monomer, a dimer, or a hexamer.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: November 17, 2020
    Assignee: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja Steinhagen, Andrea Deerberg, Erik Lattwein, Christiane Radzimski, Jana Böthfür
  • Publication number: 20190383814
    Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO1 or a variant thereof, where the recombinant polypeptide is a monomer, a dimer, or a hexamer.
    Type: Application
    Filed: February 22, 2017
    Publication date: December 19, 2019
    Applicant: EUROIMMUN Medizinische Labordiagnostika AG
    Inventors: Katja STEINHAGEN, Andrea DEERBERG, Erik LATTWEIN, Christiane RADZIMSKI, Jana BÖTHFÜR